Jiksak Bioengineering

company

About

Jiksak Bioengineering is a biotechnology company.

  • 1 - 10

Details

Last Funding Type
Series B
Industries
Biometrics,Biotechnology,Genetics,Medical,Nursing and Residential Care
Founded date
Feb 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Jiksak Bioengineering has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 23, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 23, 2021 Series B 1 CEJ Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Jiksak Bioengineering is funded by 1 investors. CEJ Capital are the most recent investors.
Investor Name Lead Investor Funding Round
CEJ Capital Yes Series B